Glenn Wilkins - Tuesday, February 18, 2025 Eupraxia Pharmaceuticals Inc. 09:43 AM EST - Eupraxia Pharmaceuticals Inc. : Today announced that it has appointed Alex Rothwell as the Company's new Chief Financial Officer, effective immediately. Eupraxia Pharmaceuticals Inc. shares T.EPRX are trading unchanged at $4.53.